Delivery Order SPE2DB22D2211-SPE2DB25FSDAH
- Not listed
- The Defense Logistics Agency awarded a $4,916.58 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Clindamycin PH 1% Solution in 60ML units. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same area. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Clindamycin PH 1% Solution in 60ml quantities, with a ceiling value of $3,394.38 and a firm fixed price structure. This delivery order is classified as non-set-aside and represents a competitively awarded contract with an ultimate completion date of August 13, 2025. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,401.76 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% Dextrose solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.64 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Clindamycin 900 mg/50 ml in Dextrose 5% Water solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.36 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in D5W solution on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,800.64 delivery order to AmerisourceBergen Drug Corp for 100 units of Clindamycin 150mg on July 29, 2025. This competitive delivery order, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical procurement supporting federal military and veteran healthcare operations. The award was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDAHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,448.80 to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ml quantities. This contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively awarded through open competition. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Clindamycin, a commonly used antibiotic, aligns with the broad therapeutic domains covered under this prime contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/15/25 |